Loading…

Neurite orientation dispersion and density imaging of the nigrostriatal pathway in Parkinson's disease: Retrograde degeneration observed by tract-profile analysis

Parkinson's disease (PD) is marked by the degeneration of dopaminergic neurons in the nigrostriatal pathway (NSP). We aimed to identify the microstructural changes in the NSP of PD patients using neurite orientation dispersion and density imaging (NODDI). NSPs of 29 PD patients, who were retros...

Full description

Saved in:
Bibliographic Details
Published in:Parkinsonism & related disorders 2018-06, Vol.51, p.55-60
Main Authors: Andica, Christina, Kamagata, Koji, Hatano, Taku, Okuzumi, Ayami, Saito, Asami, Nakazawa, Misaki, Ueda, Ryo, Motoi, Yumiko, Kamiya, Kouhei, Suzuki, Michimasa, Hori, Masaaki, Kumamaru, Kanako K., Hattori, Nobutaka, Aoki, Shigeki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Parkinson's disease (PD) is marked by the degeneration of dopaminergic neurons in the nigrostriatal pathway (NSP). We aimed to identify the microstructural changes in the NSP of PD patients using neurite orientation dispersion and density imaging (NODDI). NSPs of 29 PD patients, who were retrospectively selected from patients previously admitted to our institution, and 29 age- and gender-matched healthy controls were isolated via deterministic tractography. The NODDI indices, intracellular volume fraction (Vic), orientation dispersion index (OD), and isotropic volume fraction (Viso) were compared between the two groups. The significant results were assessed with a tract-profile analysis. The correlation between indices and disease duration or motor symptom severity was evaluated with the Pearson's correlation test. The contralateral distal Vic (p = 0.00028) of the nigrostriatal pathway was significantly lower in PD patients than in healthy controls. No correlations were detected between any of the indices and disease duration or motor symptom severity. NODDI can be used to identify retrograde degeneration of the NSP in PD patients and might be useful for monitoring the disease progression of PD. •PD is marked by the degeneration of dopaminergic neurons in the NSP.•Direct evaluation of NSP adds more value in the clinical assessment of PD.•Indices of NODDI are assumed to describe more specific microstructural changes.•NODDI can be used to identify retrograde degeneration in PD.•NODDI might be useful for monitoring the disease progression of PD.
ISSN:1353-8020
1873-5126
DOI:10.1016/j.parkreldis.2018.02.046